The effect of angiotensin-converting enzyme inhibition using captopril on energy balance and glucose homeostasis

Endocrinology

Volumn 150, Issue 9, 2009, Pages 4114-4123

  De Kloet, Annette D ^a   Krause, Eric G ^b   Kim, Dong Hoon ^b   Sakai, Randall R ^a,b   Seeley, Randy J ^a,b   Woods, Stephen C ^a,b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN I; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE; MESSENGER RNA; NEUROPEPTIDE Y;

ADIPOSE TISSUE; ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARCUATE NUCLEUS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENERGY BALANCE; ENZYME INHIBITION; FOOD INTAKE; GLUCOSE TOLERANCE; HOMEOSTASIS; HYPOTHALAMUS; LIPID DIET; LOW FAT DIET; MALE; NONHUMAN; OBESITY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; WEIGHT GAIN;

ADIPOSE TISSUE; ADMINISTRATION, ORAL; ANGIOTENSIN I; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BODY WEIGHT; CAPTOPRIL; DIETARY FATS; EATING; ENERGY METABOLISM; GLUCOSE; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SUBCUTANEOUS; MALE; NEUROPEPTIDE Y; OBESITY; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, LONG-EVANS; RENIN; RNA, MESSENGER;

EID: 69249105682     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0065     Document Type: Article

References (58)

1. Woods SC, Seeley RJ, Porte Jr D, Schwartz MW 1998 Signals that regulate food intake and energy homeostasis. Science 280:1378-1383
2. Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG 2000 Central nervous system control of food intake. Nature 404:661-671
3. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM 2006 Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295:1549-1555
4. Massiera F, Seydoux J, Geloen A, Quignard-Boulange A, Turban S, Saint-Marc P, Fukamizu A, Negrel R, Ailhaud G, Teboul M 2001 Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity. Endocrinology 142:5220-5225
5. Weisinger RS, Begg DP, Chen N, Jois M, Mathai ML, Sinclair AJ 2007 The problem of obesity: is there a role for antagonists of the renin-angiotensin system? Asia Pac J Clin Nutr 16:359-367
6. Jayasooriya AP, Mathai ML, Walker LL, Begg DP, Denton DA, Cameron-Smith D, Egan GF, McKinley MJ, Rodger PD, Sinclair AJ, Wark JD, Weisinger HS, Jois M, Weisinger RS 2008 Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance. Proc Natl Acad Sci USA 105:6531-6536
7. Engeli S, Schling P, Gorzelniak K, Boschmann M, Janke J, Ailhaud G, Teboul M, Massiéra F, Sharma AM 2003 The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol 35:807-825
8. Cassis LA, Marshall DE, Fettinger MJ, Rosenbluth B, Lodder RA 1998 Mechanisms contributing to angiotensin II regulation of body weight. Am J Physiol Endocrinol Metab 37:E867-E876
9. Fitzsimons JT 1998 Angiotensin, thirst, and sodium appetite. Physiol Rev 78:583-686
10. Krause EG, Melhorn SJ, Davis JF, Scott KA, Ma LY, de Kloet AD, Benoit SC, Woods SC, Sakai RR 2008 Angiotensin type 1 receptors in the subfornical organ mediate the drinking and hypothalamic-pituitary-adrenal response to systemic isoproterenol. Endocrinology 149:6416-6424
11. Cassis LA, Police SB, Yiannikouris F, Thatcher SE 2008 Local adipose tissue renin-angiotensin system. Curr Hypertens Rep 10:93-98
12. Lenkei Z, Palkovits M, Corvol P, Llorens-Cortès C 1997 Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front Neuroendocrinol 18:383-439
13. Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA 2004 Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol 287:R943-R949
14. Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BMW 2007 Renin-angiotensin system and cardiovascular risk. Lancet 369:1208-1219
15. Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH 1991 Association of the renin sodium profile with the risk of myocardial-infarction in patients with hypertension. N Engl J Med 324:1098-1104
16. Mori Y, Itoh Y, Tajima N 2007 Angiotensin II receptor blockers downsize adipocytes in spontaneously type 2 diabetic rats with visceral fat obesity. Am J Hypertens 20:431-436
17. Santos EL, de Picoli Souza K, Guimarães PB, Reis FCG, Silva SMA, Costa-Neto CM, Luz J, Pesquero JB 2008 Effect of angiotensin converting enzyme inhibitor enalapril on body weight and composition in young rats. Int Immunopharmacol 8:247-253
18. Shiuchi T, Iwai M, Li H-S, Wu L, Min L-J, Li J-M, Okumura M, Cui T-X, Horiuchi M 2004 Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice. Hypertension 43:1003-1010
19. Weisinger HS, Begg DP, Egan GF, Jayasooriya AP, Lie F, Mathai ML, Sinclair AJ, Wark JD, Weisinger RS 2008 Angiotensin converting enzyme inhibition from birth reduces body weight and body fat in Sprague-Dawley rats. Physiol Behav 93:820-825
20. Takahashi N, Li F, Hua K, Deng J, Wang C-H, Bowers RR, Bartness TJ, Kim H-S, Harp JB 2007 Increased energy expenditure, dietary fat wasting, and resistance to diet-induced obesity in mice lacking renin. Cell Metab 6:506-512
21. Kouyama R, Suganami T, Nishida J, Tanaka M, Toyoda T, Kiso M, Chiwata T, Miyamoto Y, Yoshimasa Y, Fukamizu A, Horiuchi M, Hirata Y, Ogawa Y 2005 Attenuation of diet-induced weight gain and adiposity through increased energy expenditure in mice lacking angiotensin II type 1a receptor. Endocrinology 146:3481-3489
22. Yvan-Charvet L, Even P, Bloch-Faure M, Guerre-Millo M, Moustaid-Moussa N, Ferre P, Quignard-Boulange A 2005 Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. Diabetes 54:991-999
23. Berne C 1991 Metabolic effects of ACE inhibitors. J Intern Med Suppl 735:119-125
24. Dominguez JR, de la Calle H, Hurtado A, Robles RG, Sancho-Rof J 1986 Effect of converting enzyme inhibitors in hypertensive patients with non-insulin-dependent diabetes mellitus. Postgrad Med J 62(Suppl 1):66-68
25. Shimabukuro M, Tanaka H, Shimabukuro T 2007 Effects of telmisartan on fat distribution in individuals with the metabolic syndrome. J Hypertens 25:841-848
26. Cooper R, Forrester T, Ogunbiyi O, Muffinda J 1998 Angiotensinogen levels and obesity in four black populations. ICSHIB Investigators. J Hypertens 16:571-575
27. Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luft FC, Sharma AM 2005 Weight loss and the renin-angiotensin-aldosterone system. Hypertension 45:356-362
28. Hainault I, Nebout G, Turban S, Ardouin B, Ferre P, Quignard-Boulange A 2002 Adipose tissue-specific increase in angiotensinogen expression and secretion in the obese (fa/fa) Zucker rat. Am J Physiol Endocrinol Metab 282:E59-E66
29. Rahmouni K, Mark AL, Haynes WG, Sigmund CD 2004 Adipose depot-specific modulation of angiotensinogen gene expression in diet-induced obesity. Am J Physiol Endocrinol Metab 286:E891-E895
30. Mathai ML, Naik S, Sinclair AJ, Weisinger HS, Weisinger RS 2008 Selective reduction in body fat mass and plasma leptin induced by angiotensin-converting enzyme inhibition in rats. Int J Obes (Lond) 32:1576-1584
31. Rowland NE, Fregly MJ 1988 Comparison of the effects of the dipeptidyl peptidase inhibitors captopril, ramipril, and enalapril on water-intake and sodium appetite of Sprague-Dawley rats. Behav Neurosci 102:953-960
32. Schiffrin EL, Genest J 1982 Mechanism of captopril-induced drinking. Am J Physiol Regul Integr Comp Physiol 242:R136-R140
33. Thunhorst RL, Fitts DA, Simpson JB 1989 Angiotensin-converting enzyme in subfornical organ mediates captopril-induced drinking. Behav Neurosci 103:1302-1310
34. Kasper SO, Carter CS, Ferrario CM, Ganten D, Ferder LF, Sonntag WE, Gallagher PE, Diz DI 2005 Growth, metabolism, and blood pressure disturbances during aging in transgenic rats with altered brain renin-angiotensin systems. Physiol Genomics 23:311-317
35. Porter JP, Potratz KR 2004 Effect of intracerebroventricular angiotensin II on body weight and food intake in adult rats. Am J Physiol Regul Integr Comp Physiol 287:R422-R428
36. Sun Y, Mendelsohn FA 1991 Angiotensin converting enzyme inhibition in heart, kidney, and serum studied ex vivo after administration of zofenopril, captopril, and lisinopril. J Cardiovasc Pharmacol 18:478-486
37. Taicher GZ, Tinsley FC, Reiderman A, Heiman ML 2003 Quantitative magnetic resonance (QMR) method for bone and whole-body-composition analysis. Anal Bioanal Chem 377:990-1002
38. Clegg DJ, Brown LM, Woods SC, Benoit SC 2006 Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes 55:978-987
39. Shi H, Strader AD, Sorrell JE, Chambers JB, Woods SC, Seeley RJ 2008 Sexually different actions of leptin in proopiomelanocortin neurons to regulate glucose homeostasis. Am J Physiol Endocrinol Metab 294:E630-E639
40. Kim DH, Sandoval D, Reed JA, Matter EK, Tolod EG, Woods SC, Seeley RJ 2008 The role of GM-CSF in adipose tissue inflammation. Am J Physiol Endocrinol Metab 295:E1038-E1046
41. Saye JA, Cassis LA, Sturgill TW, Lynch KR, Peach MJ 1989 Angiotensinogen gene expression in 3T3-L1 cells. Am J Physiol 256:C448-C451
42. Safonova I, Aubert J, Negrel R, Ailhaud G 1997 Regulation by fatty acids of angiotensinogen gene expression in preadipose cells. Biochem J 322:235-239
43. Kim S, Urs S, Massiera F, Wortmann P, Joshi R, Heo YR, Andersen B, Kobayashi H, Teboul M, Ailhaud G, Quignard-Boulangé A, Fukamizu A, Jones BH, Kim JH, Moustaid-Moussa N 2002 Effects of high-fat diet, angiotensinogen (agt) gene inactivation, and targeted expression to adipose tissue on lipid metabolism and renal gene expression. Horm Metab Res 34:721-725
44. Massiéra F, Bloch-Faure M, Ceiler D, Murakami K, Fukamizu A, Gasc JM, Quignard-Boulange A, Negrel R, Ailhaud G, Seydoux J, Meneton P, Teboul M 2001 Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J 15:2727-2729
45. Anandanadesan R, Gong Q, Chipitsyna G, Witkiewicz A, Yeo CJ, Arafat HA 2008 Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling. J Gastrointest Surg 12:57-66
46. Khakoo AY, Sidman RL, Pasqualini R, Arap W 2008 Does the renin-angiotensin system participate in regulation of human vasculogenesis and angiogenesis? Cancer Res 68:9112-9115
47. Kolonin MG, Saha PK, Chan L, Pasqualini R, Arap W 2004 Reversal of obesity by targeted ablation of adipose tissue. Nat Med 10:625-632
48. Rupnick MA, Panigrahy D, Zhang CY, Dallabrida SM, Lowell BB, Langer R, Folkman MJ 2002 Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA 99:10730-10735
49. Araki K, Masaki T, Katsuragi I, Tanaka K, Kakuma T, Yoshimatsu H 2006 Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice. Hypertension 48:51-57
50. Tabbi-Anneni I, Buchanan J, Cooksey RC, Abel ED 2008 Captopril normalizes insulin signaling and insulin-regulated substrate metabolism in obese (ob/ob) mouse hearts. Endocrinology 149:4043-4050
51. Scheen AJ 2004 Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms. Diabetes Metab 30:498-505
52. Scheen AJ 2004 Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials. Diabetes Metab 30:487-496
53. Iwai M, Chen R, Imura Y, Horiuchi M 2007 TAK-536, a new AT1 receptor blocker, improves glucose intolerance and adipocyte differentiation. Am J Hypertens 20:579-586
54. Erbe DV, Gartrell K, Zhang YL, Suri V, Kirincich SJ, Will S, Perreault M, Wang S, Tobin JF 2006 Molecular activation of PPARγ by angiotensin II type 1-receptor antagonists. Vascul Pharmacol 45:154-162
55. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P 1992 Molecular basis of human hypertension: role of angiotensinogen. Cell 71:169-180
56. Licata G, Scaglione R, Ganguzza A, Corrao S, Donatelli M, Parrinello G, Dichiara MA, Merlino G, Cecala MG 1994 Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects. Am J Hypertens 7:314-320
57. Parhofer KG, Münzel F, Krekler M 2007 Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study. Cardiovasc Diabetol 6:36
58. Gillespie EL, White CM, Kardas M, Lindberg M, Coleman CI 2005 The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes. Diabetes Care 28:2261-2266